Masimo Corporation (MASI)

Market Cap	6.99B -28.1%
Revenue (ttm)	2.18B +38.5%
Net Income	-569.40M
EPS	-10.55
Shares Out	53.71M
PE Ratio	n/a
Forward PE	22.60
Dividend	n/a
Ex-Dividend Date	n/a

Volume	905,887
Open	133.33
Previous Close	130.15
Day's Range	129.21 - 133.82
52-Week Range	125.94 - 194.88
Beta	1.27
Analysts	Buy
Price Target	188.80 (+45.06%)
Earnings Date	Feb 26, 2026

About MASI

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, methemoglobin, hemoglobin, fractional arter...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Aug 8, 2007
• Employees: 3,600
• Stock Exchange: NASDAQ
• Ticker Symbol: MASI
• Website: https://www.masimo.com

Analyst Summary

According to 6 analysts, the average rating for MASI stock is "Buy." The 12-month stock price target is $188.8, which is an increase of 45.06% from the latest price.

Price Target

$188.8

(45.06% upside)

Analyst Consensus: Buy